MDIs formulation [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2014-12-12 10:36 (4213 d 21:10 ago) – Posting: # 14061
Views: 3,261

Hi Mahesh M,

❝ do you have any reference for the same?


I don't.
I think it is a rather practical matter.

❝ We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)


Yes, you can e.g. write in your protocol that you are dosing approx. 30 secs apart and that t=0 is when the first puff is given.
By the way you don't always need to do everything strictly as per SPC for EU submissions. Other examples of SPC deviations in OIP studies include nose clips and total doses.

Good luck with your study.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
172 visitors (0 registered, 172 guests [including 45 identified bots]).
Forum time: 08:46 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5